HLA-Matched Sibling Vs. Unrelated Vs. Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: a Single-Center Donor Comparison

• Haploidentical stem cell transplantation (Haplo-SCT) is feasible in patients ≥ 60 years with acute myeloid leukemia• Unrelated donor (UD) transplantation is associated with higher incidence of acute GVHD in elderly patients• Haplo-SCT is a valuable alternative to UD in absence of matched s ibling donor

Source: Biology of Blood and Marrow Transplantation - February 12, 2018 Category: Hematology Authors: Raynier Devillier, Faezeh Legrand, J érôme Rey, Luca Castagna, Sabine Fürst, Angela Granata, Aude Charbonnier, Samia Harbi, Evelyne d'Incan, Thomas Pagliardini, Catherine Faucher, Claude Lemarie, Colombe Saillard, Boris Calmels, Bilal Mohty, Valerio Ma Source Type: research